BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16506220)

  • 1. p53 mutation spectra for squamous cell carcinomas at different levels of human bronchial branches.
    Shimmyo T; Hashimoto T; Kobayashi Y; Miyagi Y; Ishikawa Y; Nakagawa K; Osada H; Tsuchiya E
    Int J Cancer; 2006 Aug; 119(3):501-7. PubMed ID: 16506220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different subtypes of human lung adenocarcinoma caused by different etiological factors. Evidence from p53 mutational spectra.
    Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Nakagawa K; Hayashi J; Tsuchiya E
    Am J Pathol; 2000 Dec; 157(6):2133-41. PubMed ID: 11106585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
    Olshan AF; Weissler MC; Pei H; Conway K
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutational spectra are different between squamous-cell carcinomas of the lip and the oral cavity.
    Ostwald C; Gogacz P; Hillmann T; Schweder J; Gundlach K; Kundt G; Barten M
    Int J Cancer; 2000 Oct; 88(1):82-6. PubMed ID: 10962443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiologic value of p53 mutation spectra and differences with histology in lung cancers.
    Shimmyo T; Okada A; Hashimoto T; Kobayashi Y; Miyagi Y; Ishikawa Y; Nakagawa K; Osada H; Tsuchiya E
    Cancer Sci; 2008 Feb; 99(2):287-95. PubMed ID: 18271927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
    Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
    Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of p53 mutational spectra of esophageal squamous cell carcinomas from Linzhou, comparison with esophageal and other cancers from other areas].
    Wang LD; Liu B; Zheng S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Mar; 24(3):202-5. PubMed ID: 12816712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.
    Jarmalaite S; Kannio A; Anttila S; Lazutka JR; Husgafvel-Pursiainen K
    Int J Cancer; 2003 Oct; 106(6):913-8. PubMed ID: 12918069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutations and occupational exposures in a surgical series of lung cancers.
    Harty LC; Guinee DG; Travis WD; Bennett WP; Jett J; Colby TV; Tazelaar H; Trastek V; Pairolero P; Liotta LA; Harris CC; Caporaso NE
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):997-1003. PubMed ID: 8959323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
    Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
    Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck.
    Brennan JA; Boyle JO; Koch WM; Goodman SN; Hruban RH; Eby YJ; Couch MJ; Forastiere AA; Sidransky D
    N Engl J Med; 1995 Mar; 332(11):712-7. PubMed ID: 7854378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
    J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
    Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
    Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
    Le Calvez F; Mukeria A; Hunt JD; Kelm O; Hung RJ; Tanière P; Brennan P; Boffetta P; Zaridze DG; Hainaut P
    Cancer Res; 2005 Jun; 65(12):5076-83. PubMed ID: 15958551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
    Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E
    Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis.
    Ito S; Ohga T; Saeki H; Nakamura T; Watanabe M; Tanaka S; Kakeji Y; Maehara Y
    Int J Cancer; 2005 Jan; 113(1):22-8. PubMed ID: 15386362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
    Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
    Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation of p53 mutational spectra between carcinoma of the upper and lower respiratory tract.
    Law JC; Whiteside TL; Gollin SM; Weissfeld J; El-Ashmawy L; Srivastava S; Landreneau RJ; Johnson JT; Ferrell RE
    Clin Cancer Res; 1995 Jul; 1(7):763-8. PubMed ID: 9816043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Profile of p53 mutations and abnormal expression of P53 protein in 2 forms of esophageal cancer].
    Muzeau F; Fléjou JF; Potet F; Belghiti J; Thomas G; Hamelin R
    Gastroenterol Clin Biol; 1996; 20(5):430-7. PubMed ID: 8761140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.